Hims vs Ro vs Nuvari: Which Online GLP-1 and Semaglutide Provider Is Right for You?

Hims, Ro, and Nuvari are all US telehealth platforms offering compounded semaglutide and other GLP-1 protocols, but they differ in scope and positioning: Hims is a mass-market generalist, Ro is a data-driven clinical brand, and Nuvari is a premium concierge model built around eight named protocols with pharmacy-direct fulfillment. The right fit depends on price, personalization, and support depth.

This article is written by Nuvari's editorial team, so yes — we have a perspective. But we've made a deliberate effort to give Hims and Ro genuine credit where they've earned it. They have. Dismissing two publicly traded companies with millions of users and years of track record would be both dishonest and unhelpful. The goal here is to give you enough signal to make a genuinely informed decision, even if that decision isn't Nuvari.

The Honest Landscape: Telehealth Has Changed Weight Loss

A decade ago, getting a GLP-1 prescription required an in-person visit to an endocrinologist or obesity medicine specialist, often followed by weeks of insurance prior-authorization fights — if your plan covered it at all. Today, a qualified patient can complete an intake questionnaire, speak with a licensed provider, and have compounded semaglutide delivered to their door within a week. That shift is genuinely significant.

The clinical evidence behind GLP-1 therapy is also genuinely compelling. The STEP clinical trial program for semaglutide 2.4mg showed an average of approximately 15% body weight reduction over 68 weeks in study participants, with meaningful improvements in cardiometabolic markers. The SURMOUNT program for tirzepatide showed even higher average weight reduction at the highest doses — our head-to-head comparison of tirzepatide and semaglutide breaks down what the trial averages mean in practice. These are not fringe results — they represent some of the most significant pharmacological weight management data published in decades.

This demand created an opening that platforms like Hims and Ro were well-positioned to fill. Both have the regulatory infrastructure, brand recognition, provider networks, and capital to scale. More recently, a new generation of focused wellness platforms — including Nuvari — have entered with a different emphasis: deeper personalization, protocol specificity, and clinical oversight rather than breadth and volume.

None of these approaches is universally superior. The right choice depends on what you actually need.

What Each Company Does Well

Hims & Hers: Scale, Accessibility, and Brand Familiarity

Hims & Hers (NYSE: HIMS) is one of the most recognized names in telehealth, with a market capitalization exceeding $2 billion and a customer base in the millions. The company launched around men's hair loss and sexual health products before expanding into a comprehensive wellness platform covering weight management, mental health, skincare, and more for both men and women.

For GLP-1 therapy specifically, Hims has made the process frictionless. The intake is fast, pricing has generally been competitive, and the brand's ubiquity means most people have some baseline familiarity with it before they ever visit the site. The company has also invested heavily in customer experience — their app, communication cadence, and packaging reflect a premium consumer product sensibility.

Where Hims excels:

• Strong brand trust and consumer familiarity — reduces the hesitation most people feel about telehealth
• Competitive entry pricing on compounded GLP-1 programs
• Broad service menu — can address multiple health needs in one platform
• Polished product experience and professional packaging
• Established regulatory compliance history across many states

Where to calibrate expectations: Hims operates at significant scale, which means consultation processes are more standardized than individualized. The platform is designed for volume. For straightforward GLP-1 cases, that's entirely fine. For patients with complex histories or those seeking protocol customization across multiple wellness dimensions, the experience may feel more transactional.

Ro: Structured Programs and Clinical Infrastructure

Ro is another well-funded telehealth platform, having raised over $500 million in venture funding before going private again. The company operates Roman (men's health), Rory (women's health), and Zero (metabolic health), with a dedicated GLP-1 program called Ro Body.

Ro Body is specifically designed around weight management. The program includes a more structured intake process than many competitors, some integration with at-home diagnostics, and a defined protocol structure for GLP-1 therapy. The company has also been transparent about its pharmacy relationships, which matters in an era where pharmacy sourcing quality varies considerably.

Where Ro excels:

• A dedicated, structured weight management program (Ro Body) rather than GLP-1 as one of dozens of services
• Strong clinical infrastructure built over years of telehealth operation
• Relatively transparent pharmacy sourcing — a meaningful differentiator
• Some integration with lab work and metabolic health tracking
• Physician review that tends to be more thorough than simpler intake platforms

Where to calibrate expectations: Ro's pricing for GLP-1 therapy has historically been at the higher end of the compounded market. The company's women's health wing (Rory) is strong; the unified experience across programs can feel less cohesive. And like Hims, Ro's primary business is operating at scale — individualized long-term clinical partnerships are not the core model.

Nuvari: Specialization, Personalization, and Protocol Depth

Nuvari launched in 2026 as a focused wellness platform. We won't pretend to have Hims' brand recognition or Ro's decade of operational history — we don't, and we think it's important to say that plainly. What Nuvari does offer is a fundamentally different approach to how GLP-1 and peptide therapy protocols are designed and monitored.

Where Hims and Ro have built for breadth and scale, Nuvari has built for depth. Every patient has a named physician who reviews their full history, not just a prescriber completing a checklist. Protocols are designed around specific goals — weight loss, muscle preservation, recovery, hormone support, longevity — and can be layered and adjusted as those goals evolve. Pharmacy sourcing is transparent: we work exclusively with licensed US compounding pharmacies that hold appropriate state and federal accreditations.

Where Nuvari excels:

• Physician-directed protocols built around your specific goals, not templated programs
• Combination protocols — GLP-1 therapy alongside peptides, hormone support, or performance optimization — for patients who want more than a single-medication approach
• Transparent compounding pharmacy sourcing
• Ongoing clinical monitoring with real provider relationships, not just messaging portals
• Wellness-focused clinical philosophy — treating the whole picture, not just the weight number

Where to calibrate expectations: Nuvari is newer, which means less accumulated track record than Hims or Ro. If brand longevity and scale are your primary trust signals, Hims and Ro have a genuine advantage. Nuvari's pricing is also not the lowest in the market — personalized physician-directed care is more resource-intensive than standardized intake flows, and that is reflected in cost.

Side-by-Side Comparison

Pricing reflects publicly available information as of April 2026 and may change. Verify current pricing directly with each provider. All three platforms operate direct-pay models; none currently accept health insurance for GLP-1 programs.

How to Choose Based on Your Priorities

The honest answer is that no single platform is the best choice for every person. Here is a cleaner framework for thinking through it.

If your primary priority is the lowest possible monthly cost

Start with Hims. Their promotional pricing for compounded semaglutide has been among the most aggressive in the market, and for patients who are primarily price-sensitive and have a straightforward health profile, that's a real advantage. Just be clear about what's included — cheap intake processes sometimes mean less clinical support down the line.

If your primary priority is a structured, dedicated GLP-1 program

Ro Body deserves serious consideration. Ro built a program specifically around weight management rather than treating GLP-1 as one of fifty services. If you want a company whose core GLP-1 offering has been refined over years of iteration and includes cleaner lab integration and physician oversight, Ro has earned that reputation.

If your primary priority is personalization, protocol depth, or combination therapy

Nuvari is built for this. If you want to combine GLP-1 therapy with peptides for recovery or body composition, layer in hormone support, or work with a physician who will design and adjust a protocol that reflects your specific goals — not just your BMI — Nuvari's approach is meaningfully different. It's also worth considering if you've been through a GLP-1 program elsewhere and felt like you were just getting refills rather than actual clinical guidance.

If your primary priority is brand trust and track record

Both Hims and Ro have it, and Nuvari doesn't — not yet. If an established company with years of regulatory compliance history and millions of patients is what lets you trust the process, that's a legitimate reason to choose one of them. Newer platforms earn track record over time; they can't manufacture it.

What to Look for in Any Telehealth GLP-1 Provider

Regardless of which platform you choose, these are the standards that separate a trustworthy provider from a low-quality one. A reputable GLP-1 telehealth service should meet every item on this list:

• Licensed physician review, not just a questionnaire algorithm. A real, licensed provider should evaluate your intake before any prescription is issued. If the platform cannot tell you who reviews your information, that's a problem.
• Pharmacy sourcing transparency. You should be able to find out which compounding pharmacy fills your prescription and whether it holds appropriate 503A or 503B accreditation. Our guide to compounded medication safety walks through exactly what to verify. Vague answers here are a yellow flag.
• Clear contraindication screening. GLP-1 therapy is not appropriate for everyone. A provider that prescribes to anyone without reviewing personal and family health history is cutting corners that matter clinically.
• Dose escalation protocol. Starting at full dose is medically inappropriate and dramatically increases GI side effects. Our day-by-day breakdown of the first week on semaglutide shows what a well-managed titration schedule actually looks like. Any legitimate program includes a step-up titration schedule.
• Ongoing provider access. You should be able to reach a clinical professional — not just a chatbot — if you experience side effects or have questions during your protocol.
• No cure claims. GLP-1 therapy is a tool that may support weight management when combined with lifestyle changes. Any provider promising guaranteed results, fast transformations, or outcomes beyond what the clinical literature supports is misrepresenting the therapy.
• Cold-chain compliant shipping. Compounded semaglutide requires temperature-controlled shipping. Providers who ship standard ground without cold-pack packaging are compromising medication integrity.

If you're evaluating any platform — including Nuvari — hold us to every one of these standards. Ask the questions. A provider that answers them clearly and completely has earned more trust than one that deflects or buries the details in fine print.

Frequently Asked Questions

Is Hims or Ro better for semaglutide?

Both are legitimate options. Hims tends to offer lower-cost entry pricing and a broader service menu. Ro Body is a more dedicated GLP-1 program with somewhat more structured clinical oversight. Neither is objectively better — the right choice depends on whether you prioritize price, program structure, or depth of personalization. If you're weighing those tradeoffs, also consider whether a focused wellness platform like Nuvari fits your goals before deciding.

What is the cheapest way to get semaglutide online?

Compounded semaglutide accessed through a telehealth platform is currently the most affordable route, typically ranging from $149–$350 per month depending on dose and provider. Brand-name versions without insurance can run $1,000–$1,500+ monthly. When comparing costs, factor in what is included — the lowest monthly price may not include physician follow-ups, dose adjustments, or clinical monitoring, which are clinically meaningful, not just conveniences.

Can I trust compounded semaglutide from telehealth platforms?

Compounded semaglutide from a licensed 503A or 503B US compounding pharmacy is legal and regulated at both the state and federal level. The key question is whether the platform you use is transparent about which pharmacy fulfills their prescriptions and whether that pharmacy holds appropriate accreditation. Any reputable provider — Hims, Ro, or Nuvari — should be able to answer that question directly. If they can't or won't, that's a meaningful red flag.

Does Nuvari offer tirzepatide as well as semaglutide?

Yes. Nuvari offers protocols built around both semaglutide and tirzepatide, as well as peptide therapies such as BPC-157, TB-500, and CJC-1295/Ipamorelin for recovery, body composition, and performance goals. The right medication is determined by your physician based on your health history, goals, and clinical eligibility — not a default selection.

How do I choose between Hims, Ro, and Nuvari for weight loss?

Start with your priorities. If you want the lowest barrier to entry and brand familiarity, Hims is a reasonable starting point. If you want a structured, dedicated GLP-1 program from an established company, evaluate Ro Body carefully. If your priority is physician-directed personalization — especially if you want to combine GLP-1 therapy with peptides, hormone support, or performance protocols — Nuvari is specifically built for that approach. No single platform is the right answer for everyone, and the choice is worth thinking through rather than defaulting to the most-advertised option.